Pieris Pharmaceuticals Stock (NASDAQ: PIRS) stock price, news, charts, stock research, profile.
Open | $17.35 |
Close | $17.24 |
Volume / Avg. | 9.52K / 133.69K |
Day Range | $16.51 - $17.50 |
52 Wk Range | 6.20 - 27.20 |
Market Cap | $22.76M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 4.55% |
Days to Cover | 1.37 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pieris Pharmaceuticals (NASDAQ:PIRS) through any online brokerage.
Other companies in Pieris Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Evaxion Biotech (NASDAQ:EVAX), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT) and Palatin Techs (AMEX:PTN).
There is no analysis for Pieris Pharmaceuticals to provide a consensus price target.
The stock price for Pieris Pharmaceuticals (NASDAQ: PIRS) is $17.24 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Pieris Pharmaceuticals.
Pieris Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Pieris Pharmaceuticals.
Pieris Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.